Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

Overview of attention for article published in Breast Cancer Research and Treatment, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,372 followers.

男性乳がんに対してアロマターゼ阻害剤vsタモキシフェン→死亡リスクHR1.5(1.13〜2.13) タモキシフェンの方が良いかも https://t.co/xMf8XRstgw

SERM beats AI as treatment strategy of choice for MALE breast cancer: Tamoxifen yield way better results than the... http://t.co/5WXgC3Mu